Sabby Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-16,909
| Closed | -$327K | – | 115 |
|
2018
Q3 | $327K | Sell |
16,909
-1,404
| -8% | -$27.2K | 0.04% | 46 |
|
2018
Q2 | $331K | Buy |
+18,313
| New | +$331K | 0.05% | 49 |
|
2018
Q1 | – | Sell |
-14,433
| Closed | -$608K | – | 126 |
|
2017
Q4 | $608K | Sell |
14,433
-65,887
| -82% | -$2.78M | 0.06% | 38 |
|
2017
Q3 | $4.42M | Buy |
+80,320
| New | +$4.42M | 0.29% | 2 |
|
2017
Q2 | – | Sell |
-2,089
| Closed | -$250K | – | 180 |
|
2017
Q1 | $250K | Sell |
2,089
-10,536
| -83% | -$1.26M | 0.01% | 98 |
|
2016
Q4 | $1.25M | Buy |
12,625
+986
| +8% | +$97.9K | 0.07% | 45 |
|
2016
Q3 | $1.3M | Sell |
11,639
-12,111
| -51% | -$1.36M | 0.05% | 55 |
|
2016
Q2 | $2.44M | Buy |
23,750
+19,495
| +458% | +$2M | 0.13% | 34 |
|
2016
Q1 | $391K | Buy |
+4,255
| New | +$391K | 0.02% | 133 |
|
2015
Q4 | – | Sell |
-2,632
| Closed | -$272K | – | 221 |
|
2015
Q3 | $272K | Buy |
+2,632
| New | +$272K | 0.01% | 168 |
|